• June 2, 2023

Looking Into What Leen Kawas Has to Say About Investing in a Bright Future

Dr. Leen Kawas is well-known as the co-founder of Athira Pharma, a leading biotechnology firm. Since the company’s inception, Leen Kawas has mainly focused on finding a cure for neurological ailments such as Alzheimer’s disease. She later left Athira to co-found Propel Bio Partners, an equity investment firm focused on life science firms’ success and growth.

Leen Kawas is among the few female founders that have managed to stand at the helm of a firm during an IPO. Kawas is also passionate about supporting other entrepreneurs striving to make a difference in the life science sector. For the efforts that Kawas has made over the years, she has been accorded numerous honors.

About Propel Bio Partners

Propel Bio Partners is an equity investment firm mainly focused on assisting companies in the life science sector. By doing so, Propel Bio has played a vital role in improving human health. Additionally, Propel Bio ensures that its portfolio firms have access to the company’s ecosystem of medical experts, professional service providers, and operational advisors.

According to Leen Kawas, to succeed as an entrepreneur, you need the following skills:

  • Be able to operate with a mix of analytical, innovative, and strategic thinking.
  • Be able to make decisions with conviction.
  • Avoid giving up, build teams that don’t give up, and focus on having a growth mindset.

Kawas Talks About Her Future Plans

Kawas and her team at Propel Bio usually look for top innovative science and talented and creative entrepreneurs in the life science industry. Propel Bio aims to develop an engine that can advance therapies and technology to allow people to lead smarter, happier, and healthier lives. With her team of extensive operational, financial, and strategic experience, Kawas is confident that the mission of each company Propel Bio has invested in will succeed.

Original source to learn more: https://www.propelbio.com/team/leen-kawas-phd/